240550 — DongBang Medical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for DongBang Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Net Income/Starting Line	3,320	9,734	3,127	11,442
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	8,379	8,366	15,167	9,243
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-6,472	-17,372	-4,872	-16,149
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	10,499	6,176	19,536	11,557
Capital Expenditures	-6,395	-4,680	-13,180	-14,717
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-317	-3,051	-4,496	-5,550
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-6,712	-7,731	-17,676	-20,267
Financing Cash Flow Items	—	—	0.92	3,220
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	3,138	-3,481	-230	23,982
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,925	-5,036	1,630	15,273